121 related articles for article (PubMed ID: 28454273)
1. Repurposing cimetidine for cholangiocarcinoma: Antitumor effects
Dana P; Vaeteewoottacharn K; Kariya R; Matsuda K; Wongkham S; Okada S
Oncol Lett; 2017 Mar; 13(3):1432-1436. PubMed ID: 28454273
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma
Saisomboon S; Kariya R; Vaeteewoottacharn K; Wongkham S; Sawanyawisuth K; Okada S
Heliyon; 2019 May; 5(5):e01675. PubMed ID: 31193061
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antitumor activity of tiliacorinine in human cholangiocarcinoma.
Janeklang S; Nakaew A; Vaeteewoottacharn K; Seubwai W; Boonsiri P; Kismali G; Suksamrarn A; Okada S; Wongkham S
Asian Pac J Cancer Prev; 2014; 15(17):7473-8. PubMed ID: 25227861
[TBL] [Abstract][Full Text] [Related]
4. Cordycepin Inhibits Cancer Cell Proliferation and Angiogenesis through a DEK Interaction via ERK Signaling in Cholangiocarcinoma.
Liu T; Zhu G; Yan W; Lv Y; Wang X; Jin G; Cui M; Lin Z; Ren X
J Pharmacol Exp Ther; 2020 May; 373(2):279-289. PubMed ID: 32102917
[TBL] [Abstract][Full Text] [Related]
5. Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells.
Yang X; Wang S; Mu Y; Zheng Y
Oncol Rep; 2016 Oct; 36(4):1799-806. PubMed ID: 27499090
[TBL] [Abstract][Full Text] [Related]
6. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells.
Ke F; Wang Z; Song X; Ma Q; Hu Y; Jiang L; Zhang Y; Liu Y; Zhang Y; Gong W
Drug Des Devel Ther; 2017; 11():1753-1766. PubMed ID: 28670110
[TBL] [Abstract][Full Text] [Related]
7. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y
Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
[TBL] [Abstract][Full Text] [Related]
8. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
10. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
Seubwai W; Wongkham C; Puapairoj A; Okada S; Wongkham S
Cancer; 2010 Dec; 116(23):5535-43. PubMed ID: 20681031
[TBL] [Abstract][Full Text] [Related]
11. Actinidia arguta (Hardy Kiwi) Root Extract Exerts Anti-cancer Effects via Mcl-1-Mediated Apoptosis in Cholangiocarcinoma.
Zhao X; Wen F; Wang W; Lu Z; Guo Q
Nutr Cancer; 2019; 71(2):246-256. PubMed ID: 30633583
[TBL] [Abstract][Full Text] [Related]
12. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
Zhao W; Yang S; Chen J; Zhao J; Dong J
Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
[TBL] [Abstract][Full Text] [Related]
13. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: an in vivo and in vitro study.
Li S; Han Z; Ma Y; Song R; Pei T; Zheng T; Wang J; Xu D; Fang X; Jiang H; Liu L
Oncol Rep; 2014 Jan; 31(1):145-52. PubMed ID: 24247752
[TBL] [Abstract][Full Text] [Related]
14. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
Srijiwangsa P; Ponnikorn S; Na-Bangchang K
BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576
[TBL] [Abstract][Full Text] [Related]
15. The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis.
Meng F; Han Y; Staloch D; Francis T; Stokes A; Francis H
Hepatology; 2011 Nov; 54(5):1718-28. PubMed ID: 21793031
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo.
Xu D; Ma Y; Zhao B; Li S; Zhang Y; Pan S; Wu Y; Wang J; Wang D; Pan H; Liu L; Jiang H
Oncol Rep; 2014 May; 31(5):2063-70. PubMed ID: 24603952
[TBL] [Abstract][Full Text] [Related]
17. TCF21 inhibits tumor-associated angiogenesis and suppresses the growth of cholangiocarcinoma by targeting PI3K/Akt and ERK signaling.
Duan HX; Li BW; Zhuang X; Wang LT; Cao Q; Tan LH; Qu GF; Xiao S
Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G763-G773. PubMed ID: 30920845
[TBL] [Abstract][Full Text] [Related]
18. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
[TBL] [Abstract][Full Text] [Related]
19. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
Jinawath A; Akiyama Y; Sripa B; Yuasa Y
J Cancer Res Clin Oncol; 2007 Apr; 133(4):271-8. PubMed ID: 17294242
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
Koprowski S; Sokolowski K; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
J Surg Res; 2015 Oct; 198(2):434-40. PubMed ID: 25890434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]